Eureka 02001L0083-20250101 Sign in

active substance(s)

as defined in Directive 2001/83/EC of the European Parliament and of the Council of…

For vaccines for human use and by derogation from the provisions of Module 3 on ‘Active substance(s)’, the following requirements when based on the use of a Vaccine Antigen Master File system shall apply.

Open in the act with Eureka

Install the extension for EUR-Lex